Current Report Filing (8-k)
04 May 2023 - 8:05PM
Edgar (US Regulatory)
0001858028
false
0001858028
2023-04-26
2023-04-26
0001858028
NOVV:UnitsEachConsistingOfOneOrdinaryShareParValue0.0001PerShareOneRedeemableWarrantEntitlingHolderToPurchaseOneHalfOfOrdinaryShareAndOneRightEntitlingHolderToReceiveOnetenthOfOrdinaryShareMember
2023-04-26
2023-04-26
0001858028
NOVV:OrdinarySharesMember
2023-04-26
2023-04-26
0001858028
NOVV:WarrantsMember
2023-04-26
2023-04-26
0001858028
us-gaap:RightsMember
2023-04-26
2023-04-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 26, 2023
Nova
Vision Acquisition Corp.
(Exact
Name of Registrant as Specified in its Charter)
British
Virgin Islands |
|
001-40713 |
|
N/A |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
2
Havelock Road #07-12
Singapore |
|
059763 |
(Address of Principal Executive
Offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: +65 87183000
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
|
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Units, each consisting of
one Ordinary Share, par value $0.0001 per share, one Redeemable Warrant entitling the holder to purchase one half of an Ordinary
Share, and one Right entitling the holder to receive one-tenth of an Ordinary Share |
|
NOVVU |
|
NASDAQ Capital Market |
Ordinary Shares |
|
NOVV |
|
NASDAQ Capital Market |
Warrants |
|
NOVVW |
|
NASDAQ Capital Market |
Rights |
|
NOVVW |
|
NASDAQ Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
4.01. Changes in Registrant’s Certifying Accountant.
Effective
April 26, 2023, Nova Vision Acquisition Corp. (the “Company”) dismissed its independent auditor, Marcum LLP. The Audit Committee
(the “Audit Committee”) of the Board of Directors of the Company recently completed a comprehensive selection process to
determine what audit firm would serve as the Company’s independent registered public accounting firm for the year ending December
31, 2023 and both the Audit Committee and the Board of Directors of the Company approved the engagement of Malone Bailey LLP as the Company’s
independent registered public accounting firm for the year ending December 31, 2023.
Marcum
LLP’s audit report on the Company’s financial statements as of and for the fiscal year ended December 31, 2022 (the “Audit
Report”) did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit
scope or accounting principles, except that the Audit Report included an explanatory paragraph indicating that there was substantial
doubt about the Company’s ability to continue as a going concern. Furthermore, during the Company’s most recent fiscal year
and through April 26, 2023, there have been no disagreements with Marcum LLP on any matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedure, which disagreements, if not resolved to Marcum LLP’s satisfaction, would have
caused Marcum LLP to make reference to the subject matter of the disagreement in connection with its reports on the Company’s financial
statements for such period.
For
the fiscal year ended December 31, 2022 and through April 26, 2023, there were no “reportable events” as that term is described
in Item 304(a)(1)(v) of Regulation S-K.
The
Company provided Marcum LLP with a copy of the disclosure contained herein, prior to its filing with the Securities and Exchange Commission
(the “Commission”), and requested that Marcum LLP furnish the Company a letter addressed to the Commission stating whether
or not it agreed with the statements herein and, if not, stating the respects in which it does not agree. Marcum LLP’s letter to
the Commission is attached hereto as Exhibit 16.1.
During
the Company’s most recent fiscal year and through April 26, 2023, neither the Company nor anyone acting on the Company’s
behalf consulted Malone Bailey LLP with respect to any of the matters or reportable events set forth in Item 304(a)(2)(i) and (ii) of
Regulation S-K.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Nova Vision Acquisition Corp. |
|
|
Dated: May 3, 2023 |
/s/ Eric
Ping Hang Wong |
|
Eric Ping Hang Wong |
|
Chief Executive Officer and Chief Financial Officer |
Nova Vision Acquisition (NASDAQ:NOVVU)
Historical Stock Chart
From Jul 2024 to Aug 2024
Nova Vision Acquisition (NASDAQ:NOVVU)
Historical Stock Chart
From Aug 2023 to Aug 2024